Dannex Ayrton Starwin (XGHA:DASPHARMA) Marketable Securities: GHS0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:DASPHARMA Dannex Ayrton Starwin PLC XGHA:DASPHARMA
4 GF Score
Price GHS0.48
! 1 Warning Sign
View Full Analysis

What is Dannex Ayrton Starwin Marketable Securities?

Dannex Ayrton Starwin XGHA:DASPHARMA 4 Marketable Securities is GHS0.00 Mil as of . 20. GuruFocus rates XGHA:DASPHARMA with a GF Score™ of 4/100. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Dannex Ayrton Starwin's Marketable Securities for the quarter that ended in . 20 was GHS0.00 Mil.

Dannex Ayrton Starwin  (XGHA:DASPHARMA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Dannex Ayrton Starwin Marketable Securities Related Terms

Dannex Ayrton Starwin Marketable Securities Historical Data

* Premium members only.

The historical data trend for Dannex Ayrton Starwin's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dannex Ayrton Starwin Marketable Securities Chart

Dannex Ayrton Starwin Annual Data
Trend
Marketable Securities

Dannex Ayrton Starwin Semi-Annual Data
Marketable Securities
XGHA:DASPHARMA
4GF Score
Dannex Ayrton Starwin PLC XGHA:DASPHARMA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dannex Ayrton Starwin Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of GHS0.00 Mil mean?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a Marketable Securities of GHS0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Dannex Ayrton Starwin and its competitors.
Is Dannex Ayrton Starwin's Marketable Securities too high?
Dannex Ayrton Starwin's current Marketable Securities is GHS0.00 Mil. Overall, Dannex Ayrton Starwin has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Dannex Ayrton Starwin's Marketable Securities compare to ?
Dannex Ayrton Starwin's Marketable Securities of GHS0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Dannex Ayrton Starwin and its competitors. Dannex Ayrton Starwin's current Marketable Securities is GHS0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dannex Ayrton Starwin stock overvalued right now?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a current Marketable Securities of GHS0.00 Mil. The current Marketable Securities is GHS0.00 Mil. Dannex Ayrton Starwin's overall GF Score™ is 4/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Dannex Ayrton Starwin (XGHA:DASPHARMA), the current Marketable Securities is GHS0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dannex Ayrton Starwin Business Description

Comparable Companies
Address No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.
4GF Score

Get the complete analysis for XGHA:DASPHARMA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.48
Price